These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 16343858)

  • 21. Simplified dosing regimens of teicoplanin for patient groups stratified by renal function and weight using Monte Carlo simulation.
    Yamada T; Nonaka T; Yano T; Kubota T; Egashira N; Kawashiri T; Oishi R
    Int J Antimicrob Agents; 2012 Oct; 40(4):344-8. PubMed ID: 22818770
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacodynamics of dalbavancin studied in an in vitro pharmacokinetic system.
    Bowker KE; Noel AR; MacGowan AP
    J Antimicrob Chemother; 2006 Oct; 58(4):802-5. PubMed ID: 16891629
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Teicoplanin: Part 1. An evaluation of the concentrations seen in serum and the subcutaneous fat of the relatively ischaemic lower limb following a single intravenous bolus.
    Antrum RM; Bibby SR; Ramsden CH; Kester RC
    Drugs Exp Clin Res; 1989; 15(1):21-3. PubMed ID: 2526008
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics of dalbavancin in plasma and skin blister fluid.
    Nicolau DP; Sun HK; Seltzer E; Buckwalter M; Dowell JA
    J Antimicrob Chemother; 2007 Sep; 60(3):681-4. PubMed ID: 17631507
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Penetration of teicoplanin into heart valves and subcutaneous and muscle tissues of patients undergoing open-heart surgery.
    Frank UK; Schmidt-Eisenlohr E; Mlangeni D; Schindler M; Hoh A; Beyersdorf F; Daschner FD
    Antimicrob Agents Chemother; 1997 Nov; 41(11):2559-61. PubMed ID: 9371368
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Teicoplanin population pharmacokinetic analysis in hospitalized patients.
    Soy D; López E; Ribas J
    Ther Drug Monit; 2006 Dec; 28(6):737-43. PubMed ID: 17164688
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inadequate antimicrobial prophylaxis during surgery: a study of beta-lactam levels during burn debridement.
    Dalley AJ; Lipman J; Venkatesh B; Rudd M; Roberts MS; Cross SE
    J Antimicrob Chemother; 2007 Jul; 60(1):166-9. PubMed ID: 17504805
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Piperacillin penetration into tissue of critically ill patients with sepsis--bolus versus continuous administration?
    Roberts JA; Roberts MS; Robertson TA; Dalley AJ; Lipman J
    Crit Care Med; 2009 Mar; 37(3):926-33. PubMed ID: 19237898
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An audit of efficacy and toxicity of teicoplanin versus vancomycin in febrile neutropenia: is the different toxicity profile clinically relevant?
    Hahn-Ast C; Glasmacher A; Arns A; Mühling A; Orlopp K; Marklein G; Von Lilienfeld-Toal M
    Infection; 2008 Feb; 36(1):54-8. PubMed ID: 18193385
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics and pharmacodynamics of epoetin delta in two studies in healthy volunteers and two studies in patients with chronic kidney disease.
    Smith WB; Dowell JA; Pratt RD
    Clin Ther; 2007 Jul; 29(7):1368-80. PubMed ID: 17825688
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Albumin concentration significantly impacts on free teicoplanin plasma concentrations in non-critically ill patients with chronic bone sepsis.
    Brink AJ; Richards GA; Lautenbach EE; Rapeport N; Schillack V; van Niekerk L; Lipman J; Roberts JA
    Int J Antimicrob Agents; 2015 Jun; 45(6):647-51. PubMed ID: 25819167
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Comparative study of treatment with quinupristin-dalfopristin alone or in combination with gentamicin, teicoplanin, imipenem or levofloxacin in experimental endocarditis due to a multidrug-resistant Enterococcus faecium].
    Pérez Salmerón J; Martínez García F; Roldán Conesa D; Lorente Salinas I; López Fornás F; Ruiz Gómez J; Gómez Gómez J; Segovia Hernández M; Valdés Chávarri M
    Rev Esp Quimioter; 2006 Sep; 19(3):258-66. PubMed ID: 17099794
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.
    Dösch AO; Ehlermann P; Koch A; Remppis A; Katus HA; Dengler TJ
    Clin Ther; 2006 Jun; 28(6):893-905. PubMed ID: 16860172
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The protective effects to the function of kidney and long by clearing of cytokines in patients with open-heart surgery].
    Zhang GH; Hou FF; Wang WJ; Zhang X; Wu H; Liu ZQ; Tao HQ
    Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(45):3194-8. PubMed ID: 16405839
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of arterio-venous haemofiltration on teicoplanin elimination.
    Hillaire-Buys D; Peyriere H; Lobjoie E; Bres J; Ossart M; Despaux E
    Br J Clin Pharmacol; 1995 Jul; 40(1):95-7. PubMed ID: 8527277
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma and tonsillar tissue pharmacokinetics of teicoplanin following intramuscular administration to children.
    Aarons L; Rowland M; Khan A; Taborelli G; Ferrea G; Tarantino V; Fioredda F; Rosina-Parenti R; Cavenaghi L; Borgonovi M
    Eur J Pharm Sci; 1998 Oct; 6(4):265-70. PubMed ID: 9795079
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of teicoplanin in patients undergoing chronic haemodialysis.
    Papaioannou MG; Marinaki S; Pappas M; Stamatiadis D; Giamarellos-Bourboulis EJ; Giamarellou H; Stathakis C
    Int J Antimicrob Agents; 2002 Mar; 19(3):233-6. PubMed ID: 11932147
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Health economics assessment study of teicoplanin versus vancomycin in Gram-positive infections.
    Portolés A; Palau E; Puerro M; Vargas E; Picazo JJ
    Rev Esp Quimioter; 2006 Mar; 19(1):65-75. PubMed ID: 16688294
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Variability in teicoplanin protein binding and its prediction using serum albumin concentrations.
    Yano R; Nakamura T; Tsukamoto H; Igarashi T; Goto N; Wakiya Y; Masada M
    Ther Drug Monit; 2007 Aug; 29(4):399-403. PubMed ID: 17667792
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Uptake of teicoplanin by isolated rat hepatocytes: comparison with in vivo hepatic distribution.
    Reinoso RF; Telfer BA; Brennan BS; Rowland M
    Drug Metab Dispos; 2001 Apr; 29(4 Pt 1):453-9. PubMed ID: 11259330
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.